- HCA Missouri hospital taps new COO
- Drug use by state in 2026
- Dental hygienists, assistants not satisfied with their income
- ChristianaCare to build $58.1M health campus
- Franciscan Health, US HealthVest partner on behavioral care
- California cardiology practices suffers email security incident
- Trinity Health CEO’s plan to drive 75% of revenue from community-based care
- Delta Dental to pay $2.2M penalty for violating cybersecurity regulations
- 6 DSOs expanding on the West Coast
- 7 behavioral health facility, service closures, layoffs in 2026
- Physicians’ million-dollar pay gap problem
- Decades-old formula error may be causing hospitals to underbudget nursing staff: 4 notes
- Top 10 dental, DSO stories in April
- The ASC group betting that physician ownership beats the employed model
- FDA seeks to restrict compounding of key GLP-1s
- Cigna to exit ACA individual business, posts $1.65B Q1 profit
- Modernizing Medication Workflows in an Effort to Reduce Nursing Burden
- UMass Chan: AI outperforms biopsy in cancer diagnosis
- ‘Providers are part of the issue too’: Hackensack Meridian CEO outlines affordability strategy
- Change management and intentional design: Key success factors for patient blood management programs
- Dentrix Ascend integrates Pearl’s dental AI
- New Medical Guidelines Urge More Fiber, Less Bathroom Scrolling on Your Phone
- Northwestern opens $15M endoscopy center
- Which physicians are the most pessimistic, optimistic about their future? A breakdown
- CRNA group honors Oregon congresswoman
- VCU Health breaks ground on outpatient heart center
- Sleep and Anxiety Medications in Pregnancy Appear to Pose Little Harm
- UMass acquires cardiology group
- Lilly touts 'encouraging' early days for Foundayo obesity launch, even as GLP-1 pill appears to lag Novo's
- BMS 'well prepared' for Camzyos competition as revenue from new products overtakes legacy portfolio
- Waystar kicks off 2026 with strong growth as it targets AI at $100B RCM labor pool
- Merck's growth products Winrevair, Ohtuvayre trending in opposite directions
- Trump's Medicaid Work Mandate Debuting in Nebraska to Much Dismay
- Prehabilitation Slashes Post-Op Complications By Half, Review Says
- Nasal Spray Flu Vaccines Create 'Battlefield' In Adults' Noses
- Understanding Emotions Could Be Key To Quelling Chronic Pain
- Meth Caused 1 In 6 Heart Attacks Over A Decade, Study Finds
- When Natural Disasters Strike, Another Crisis Hits Those Recovering From Opioid Addiction
- States Rush To Figure Out How To Enforce Trump’s Medicaid Work Requirements
- Cigna posts $1.65B in profit in Q1 earnings beat
- Amarox recalls batch of antidepressants in UK over packaging mix-up
- Bayer earns FDA untitled letter for Nubeqa's 'attention-grabbing visuals'
- Merck bats for heart disease awareness with new baseball-inspired campaign
- Avalyn heads to Nasdaq with oversized $300M IPO to fund reformulated respiratory drugs
- Europe’s drug regulator sets up new group to counter vaccine hesitancy
- Maine law increases oversight of healthcare transactions: 6 notes for dental leaders
- Align Technology sees 6.2% increase in Q1 revenue: 7 notes
- Aidoc banks $150M backed by Goldman Sachs to scale clinical AI foundation model
- 8 behavioral healthcare M&A deals in 2026
- Maryland autism therapy provider expands in-home services in Colorado
- ‘There are no easy solutions’: What dental leaders told us in April
- Connecticut House passes bill authorizing at-home dental hygiene visits
- Delaware physician to pay $180K to settle fraud allegations
- Tennessee specialist group joins Maury Regional Medical Group
- Aviation, hospitality and the NFL: What dentistry can learn from other industries
- 22 behavioral health executive moves to know
- The ‘significant opportunity’ Talkspace will bring to UHS
- Healthcare costs remain a top concern for voters as midterms loom: KFF
- UHS-owned behavioral health facility to lay off 648 employees
- Nonprofit health systems are falling short on governance capabilities, report warns
- Novartis rounds out $23B US investment push with plans for North Carolina API plant
- Teladoc Health reports strong momentum behind BetterHelp insurance shift, CEO says
- AI Tool May Help Identify ADHD in Kids Long Before Typical Diagnosis
- Federal autism committee outlines policy, care gaps in HHS letter
- Tennessee provider expands virtual behavioral health urgent care
- Viz.ai partners with National Rural Health Association to expand AI understanding, access to rural hospitals
- FDA Moves to Real-Time Clinical Trial Patient Monitoring, Faster Drug Review
- AstraZeneca CEO's conservative MFN model excludes reference markets from forecast
- With Austedo at helm, Teva's impressive innovative drug sales signal company's successful metamorphosis
- Universal Health Services' Q1 2026 earnings growth dampened by volume hits
- AbbVie outlines Skyrizi defense against new J&J plaque psoriasis rival Icotyde
- Regeneron's quarterly sales of Eylea drop below $1B for the first time in 8 years
- Only 1 in 4 employers able to ‘absorb’ increasing health benefit costs without impacting business
- Dementia Screening Safe For Families, Trial Finds
- Online Program Soothes Post-Trauma Stress In Injured Children
- Mental Defeat Can Worsen Chronic Pain, Researchers Say
- Pooled Umbilical Cord Blood Boosts Stem Cell Transplant Success, Trial Finds
- New GSK CEO’s first quarter boosted by Shingrix surge as Exdensur stumbles in switch trial
- AstraZeneca restarts £300M investment in UK, but Merck not budging
- Chiesi lays out $1.9B to bolster rare disease offerings with KalVista buyout
- US drugmaker’s reputations shift quickly amid political pressures, job cuts: survey
- Trump’s Medicaid Work Mandate Debuting in Nebraska to Much Dismay
- Saving Lives by Changing Lives: The Next Frontier in Suicide Prevention
- Pfizer looks to jump start Elrexfio with topline win in second-line myeloma
- The push to expand access to emergency contraception
- Humana pulls back the curtain on planning for 2027 MA bids
- On Capitol Hill, health system CEOs agree to 'rational reworking' of site-neutral payments
- Novartis CEO calls for 'complete rethink' of Europe's drug pricing policies
- Secret to Surviving 'Perfect Mom' Posts on Social Media Revealed
- Pfizer’s victory in delaying Vyndamax generics is mixed bag for BridgeBio: analysts
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Getting All Your Ducks in a Row to IPO: Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Remarks to the Small Business Capital Formation Advisory Committee
- FDA flags concerns for AstraZeneca's camizestrant, Truqap ahead of advisory committee meeting
- CDC Warns of Antibiotic-Resistant Salmonella in Backyard Flocks
- Listen to the Latest ‘KFF Health News Minute’
- AI-driven coding platform Arintra rolls out new documentation improvement capabilities
- Florida Delays Children's Health Insurance Expansion as Uninsured Rate Rises
- Interoperability was Never the Finish Line in Healthcare
- Interoperability was Never the Finish Line in Healthcare
- IKS Health to acquire TruBridge in $557M deal
- FDA turns up heat on Amgen, proposing to rescind approval of Tavneos
- Rocket sells priority review voucher for $180M after Kresladi gene therapy approval
- Big companies position themselves for payday from $50B federal rural health fund
- AZ's Breztri nabs FDA asthma nod, adding fuel to blockbuster launch
- Daylight Saving Time Fails to Boost Daily Steps, Study Finds
- Metabolic Syndrome Tied To Cancer Risk
- Mail-In Colon Cancer Test Kits Offer Affordable Screening
- U.S. Dentists Still Overprescribing Opioids Compared To Other Nations, Puerto Rico
- An Urgent Care Treated Her Allergic Reaction. An ER Monitored Her — For $6,700.
- Big Companies Position Themselves for Payday From $50B Federal Rural Health Fund
- Centene swings to $1.5B profit as Medicaid business improves even as ACA membership falls by 2 million
- CCS deploys enterprise-wide agentic AI across chronic care operations
- Utah Medical Licensing Board urges state to shut down Doctronic AI prescribing pilot
- Estrogen Patch Shortages Likely Driven By Empowered Women Seeking Relief, Expert Says
- Medical professional liability premiums rise for 7th straight year
- UChicago Medicine, Artisight partner on system-wide rollout of smart hospital platform
- Solace Health expands care navigation services to commercially insured patients
- First Gene Therapy for Genetic Hearing Loss, Otarmeni, Gains FDA Approval
- CMS Extends Medicare's Short-Term Bridge Program for GLP-1 Obesity Drug Coverage
- Humana's CenterWell, Mark Cuban Cost Plus Drugs partner to tackle employers' drug costs
- AMA urges lawmakers to implement stronger safeguards for AI chatbots in mental health
- Blood Glucose Monitors Improve Control Among Type 2 Diabetes Patients
- Regaining Weight After Quitting Your GLP-1 Drug? A Simple Procedure Might Help, Study Says
- Late-Night Noshing Could Contribute To Stress-Related Bathroom Problems
- New Treatment Targets Unaddressed Major Symptom Of Depression Through Joy, Pleasure and Purpose
- Florida Delays Children’s Health Insurance Expansion as Uninsured Rate Rises
- The Help That Many Older Americans Need Most
- Why Pricier Olive Oil May Be Better For Your Brain
- Your Internal Signal to Stop Eating is More Complex Than Previously Thought
- Gounder Culls the News, From Ticks and AI to Who Might Lead CDC
- FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order
- Green Lighting Capital Formation: Remarks at the SEC International Institute on Capital Formation
- With ‘lessons learned,’ Kite prepares to hit the ground running as next-gen CAR-T decision looms
- Former Tobacco Executive Takes CDC Role
- New Plan Could Speed Medicare Coverage for Innovative Devices
- Heated Socks Sold at Costco Recalled After Burn Reports
- First Measles Case of the Year Reported in New Jersey
- CMS, FDA Announce RAPID Coverage Pathway to Accelerate Device Reimbursement
- CMS, FDA Announce RAPID Coverage Pathway to Accelerate Device Reimbursement
- Does Motherhood Shield You From Stroke?
- These Fun Pursuits Help Middle-Aged Folks Protect Brain Health, Study Finds
- New Guidelines Highlight Behavioral Therapy For Insomnia
- Playing Pretend Provides Unexpected Benefits For Growing Kids
- New Survey Estimates 8 Million Americans Used Psilocybin in 2024
- Eye Photos Might Offer Early Warning Of Chronic Health Problems, AI Study Finds
- Opening Remarks at the 32nd Annual International Institute for Securities Market Growth and Development
- Keynote Remarks at The Economic Club of Washington
- Statement on the Amendments to Form PF
- Update on the SEC’s Work Toward Treasury Clearing Implementation
Chris Pope of The Manhattan Institute believes that preventing states from creating new, extraneous programs and funding them with Medicaid dollars is the best way to cut Medicaid spending. A good idea, but unlikely to actually cut Medicaid spending. More likely to reduce the explosive growth of Medicaid spending which has occurred in this century. Federal Medicaid expenditures have increased from $ 118 billion in FY2000 to $ 557 billion in FY2024, a 472% increase:
https://www.city-journal.org/article/house-republicans-medicaid-spending-proposals
A Better Way to Cut Medicaid Spending
The House GOP’s current plans won’t significantly reduce the program. Republicans should instead seek to slow states’ expansions of it.
By Chris Pope - May 20, 2025Last week, House Republicans unveiled proposals to reform Medicaid, the fast-growing system of federal funding for states to deliver health care to low-income Americans. Their proposal creates the appearance of generating substantial savings by nudging states to restrict enrollment. But the approach is unlikely to slow the overall growth of Medicaid spending, because it does little to reduce states’ ability and incentive to claim ever more federal funding.
In reality, Republicans, who promised not to threaten care for those enrolled, have been unable to identify substantial savings by cutting funds that states rely on to deliver health care to Medicaid enrollees. They would do better to focus on the politically easier and fiscally more significant task of preventing states from further expanding the program’s commitments.
Liberals responded to the House’s modest proposals with predictable outrage. Matthew Yglesias has called it a “War on the poor,” arguing that “Medicaid cuts contained in the bill will cause 8.6 million people to lose their health insurance.” Massachusetts representative Lori Trahan has deemed it “federal overreach, plain and simple, with devastating consequences for the people we represent.”
Critics’ outrage is surely overdone. From 2003 to 2023, Medicaid’s annual cost to federal taxpayers surged from $161 billion to $616 billion. House Republicans’ proposals would merely slow the program’s further spending growth over the coming decade from 4.6 percent per year to 3.7 percent. Even that reduction in growth is likely to overestimate the savings that would occur.
To offset the cost of extending the 2017 tax cuts, the House GOP has attempted to maximize the Congressional Budget Office’s estimate of savings resulting from its proposed reforms to Medicaid. But CBO estimates don’t account for likely hurdles to implementation, such as states finding ways to evade intended cost controls.
When such hurdles are considered, the savings and coverage loss are both much less than they’re cracked up to be. This is by design—and it reflects the GOP’s tiny majorities in both houses of Congress, combined with political pressure from governors and health-care providers who stand to lose revenues.
Opponents of the bill point to major cuts in coverage, which the CBO suggests would generate reductions in spending. Loren Adler and Matthew Fiedler of the Brookings Institution, for example, argue that “House Republicans are cutting health coverage programs in two basic ways: (1) narrowing eligibility and making it harder to enroll and stay enrolled; and (2) shifting Medicaid costs from the federal government to the states.” But neither of these effects are likely to be that large.
Take the bill’s work requirements. Adler and Fielder concede that work requirements would not greatly narrow eligibility because the “overwhelming majority of affected enrollees are already working or otherwise complying.” But they suggest that the administrative burden of demonstrating compliance may lead many who are eligible to lose benefits.
That seems unlikely. The bill allows part-time “community engagement” activities to satisfy work requirements, and states have proven adept at using token employment arrangements to nullify similar mandates in the past. The bill would not even allow states to implement work requirements for several years.
States currently receive up to $9 in federal funds for every $1 they spend on Medicaid benefits for able-bodied adults—a return on investment that even most conservative states have found hard to resist. An important objective of work requirements appears to be giving the remaining holdouts political cover to claim their own portion of the federal bounty by expanding Medicaid. This would greatly increase, rather than reduce, federal spending and Medicaid enrollment—even if CBO does not account for such considerations.
Republicans argue that it’s absurd for the federal government to provide $9 in funding for every $1 states spend on Medicaid benefits for able-bodied adults, while only providing an average of $1.30 for every $1 spent on benefits for children, the disabled, and pregnant women. President Obama proposed replacing this arrangement with an intermediary rate for all beneficiaries, but Republicans plan simply to reduce the higher rate.
Democrats argue that the proposed reduction of funding for states would lead to major cuts in coverage. But the GOP bill would only trim the $9-to-$1 match to $8-to-$1 for blue states whose Medicaid providers also deliver care to illegal immigrants—leaving an enormously lucrative arrangement largely in place. The reduction is more an attempt to influence states’ policies on immigration than an effort to lessen substantially the burden on federal taxpayers.
The House GOP bill may nonetheless generate some modest genuine savings. It tightens enforcement of means tests and attempts to restrict states’ ability to inflate federal matching funds artificially by imposing state taxes on insurers, hospitals, and other medical providers. But similar restrictions on “provider taxes” have been enacted in the past and tend to proceed like a game of Whac-a-Mole: whenever Congress restricts one scheme to inflate Medicaid costs artificially, states construct another.
The only real way to stop states from driving up Medicaid costs is to limit the total amount of federal Medicaid funding each state may claim. This year’s House GOP proposal, unlike the 2017 version, doesn’t even try to do so. The GOP has previously stumbled in attempting to set precise dollar limits on Medicaid funding for states. (Set them too high, and they will do little to constrain the growth of expenditures; too low, and they will unduly disrupt existing care.)
A better approach would be to prohibit high-spending states from unilaterally expanding their Medicaid programs. States that claim more than $20,000 in federal Medicaid funds per poor resident should no longer be permitted to claim additional matching funds for further expansions of benefit packages or eligibility, or extraordinary increases in payments for services undertaken without express authorization by Congress.
The House GOP’s Medicaid reform proposals have failed to generate substantial genuine savings or improvements to the program. Their Republican Senate counterparts have an opportunity to do better.
Christopher Pope is a senior fellow at the Manhattan Institute. Previously, he was director of policy research at West Health, a nonprofit medical research organization; health-policy fellow at the U.S. House Committee on Energy and Commerce; and research manager at the American Enterprise Institute. Pope’s research focuses on healthcare payment policy, and he has recently published reports on hospital-market regulation, entitlement design, and insurance-market reform. His work has appeared in, among others, the Wall Street Journal, Health Affairs, US News and World Report, and Politico.
Pope holds a B.Sc. in government and economics from the London School of Economics and an M.A. and Ph.D. in political science from Washington University in St. Louis.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















